CYTK

50.7801.32%
RI

Robert I. Blum

CEO, President & Director

Mr. Robert I. Blum has been Chief Executive Officer, President and Director of Cytokinetics, Incorporated since January 22, 2007 and served as its Principal Financial Officer until May 08, 2024. Mr. Blum previously served as President from February 2006 to January 2007, Executive Vice President of Corporate Development and Commercial Operations and Chief Business Officer from September 2004 to February 2006, Executive Vice President of Corporate Development and Finance and Chief Financial Officer from January 2004 to September 2004, Senior Vice President of Corporate Development and Finance and Chief Financial Officer from October 2001 to December 2003 and Vice President of Business Development from July 1998 to September 2001 at Cytokinetics, Incorporated and also served as its Principal Accounting Officer and Secretary. Prior to joining Cytokinetics in July 1998, he held senior positions in Business Development and Marketing at COR Therapeutics from 1991 to 1998. He served as Director, Marketing at COR Therapeutics, Inc., a biopharmaceutical company, since 1996. From 1991 to 1996, he was Director, Business Development at COR Therapeutics. Prior to that, Mr. Blum performed roles of increasing responsibility in sales, marketing and other pharmaceutical business functions at Marion Laboratories, Inc. and Syntex Corporation (now part of Roche Holding AG) from 1981. Mr. Blum had been Chairman of Gamida Cell Ltd. since September 18, 2018 until March 21, 2023. In addition, he established the Tikkun Olam Youth Science Prizes for Bay Area middle and high schools designed to further science education and exploration in the spirit of repairing the world. Mr. Blum serves on the Board of the Jewish Community Federation of San Francisco and founded and chaired its Business Leadership Council. He has also served on the Boards of San Francisco's Contemporary Jewish Museum and the Anti-Defamation League. He is on faculty at the Center for BioEntrepreneurship at UC San Francisco where he has taught a corporate finance course to graduate students. He is a frequent lecturer on matters of business development and finance in the biopharmaceutical industry. Mr. Blum was named a Henry Crown Fellow of the Aspen Institute in recognition of his leadership in corporate and civic responsibilities. Mr. Blum received B.A. degrees in Human Biology and Economics from Stanford University and an M.B.A. from Harvard Business School.

Positions